Penumbra Operating Margin 2014-2025 | PEN
Penumbra Operating Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Operating Income | Operating Margin |
2025-06-30 | $1.28B | $0.16B | 12.42% |
2025-03-31 | $1.24B | $0.04B | 2.98% |
2024-12-31 | $1.20B | $0.01B | 0.75% |
2024-09-30 | $1.16B | $0.00B | 0.09% |
2024-06-30 | $1.13B | $-0.02B | -1.85% |
2024-03-31 | $1.10B | $0.08B | 7.12% |
2023-12-31 | $1.06B | $0.07B | 6.99% |
2023-09-30 | $0.99B | $0.04B | 4.43% |
2023-06-30 | $0.94B | $0.04B | 3.84% |
2023-03-31 | $0.88B | $0.02B | 2.04% |
2022-12-31 | $0.85B | $0.01B | 0.71% |
2022-09-30 | $0.83B | $-0.04B | -4.70% |
2022-06-30 | $0.81B | $-0.04B | -4.34% |
2022-03-31 | $0.78B | $-0.03B | -3.20% |
2021-12-31 | $0.75B | $-0.01B | -1.07% |
2021-09-30 | $0.71B | $0.03B | 4.23% |
2021-06-30 | $0.67B | $0.00B | 0.15% |
2021-03-31 | $0.59B | $-0.03B | -4.56% |
2020-12-31 | $0.56B | $-0.04B | -6.96% |
2020-09-30 | $0.54B | $-0.03B | -4.83% |
2020-06-30 | $0.53B | $0.01B | 1.33% |
2020-03-31 | $0.56B | $0.04B | 6.83% |
2019-12-31 | $0.55B | $0.05B | 8.78% |
2019-09-30 | $0.52B | $0.04B | 8.41% |
2019-06-30 | $0.50B | $0.01B | 2.02% |
2019-03-31 | $0.47B | $0.01B | 1.27% |
2018-12-31 | $0.45B | $0.00B | -0.22% |
2018-09-30 | $0.42B | $0.00B | -0.95% |
2018-06-30 | $0.39B | $0.02B | 4.58% |
2018-03-31 | $0.36B | $0.01B | 2.20% |
2017-12-31 | $0.33B | $0.00B | 0.60% |
2017-09-30 | $0.31B | $0.00B | -0.96% |
2017-06-30 | $0.29B | $-0.01B | -1.70% |
2017-03-31 | $0.28B | $-0.01B | -1.80% |
2016-12-31 | $0.26B | $0.00B | -0.38% |
2016-09-30 | $0.24B | $0.00B | 0.82% |
2016-06-30 | $0.23B | $0.01B | 2.20% |
2016-03-31 | $0.20B | $0.00B | 0.98% |
2015-12-31 | $0.19B | $0.00B | 2.16% |
2015-06-30 | $0.11B | 0 | 0.00% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $9.340B | $1.195B |
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $174.604B | 21.12 |
Intuitive Surgical (ISRG) | United States | $169.147B | 70.11 |
IDEXX Laboratories (IDXX) | United States | $52.172B | 54.30 |
Edwards Lifesciences (EW) | United States | $45.888B | 30.41 |
Alcon (ALC) | Switzerland | $41.768B | 28.23 |
IQVIA Holdings (IQV) | United States | $30.615B | 17.30 |
DexCom (DXCM) | United States | $30.529B | 45.79 |
Mettler-Toledo (MTD) | United States | $25.882B | 30.72 |
STERIS (STE) | Ireland | $23.797B | 25.33 |
Waters (WAT) | United States | $16.625B | 22.84 |
SONOVA HOLDING (SONVY) | Switzerland | $16.421B | 0.00 |
Hologic (HOLX) | United States | $15.122B | 16.38 |
Sysmex ADR (SSMXY) | Japan | $8.668B | 27.54 |
Globus Medical (GMED) | United States | $8.046B | 18.51 |
Masimo (MASI) | United States | $8.006B | 26.94 |
Teleflex (TFX) | United States | $5.124B | 8.27 |
Glaukos (GKOS) | United States | $4.991B | 0.00 |
TransMedics (TMDX) | United States | $4.338B | 65.94 |
Integer Holdings (ITGR) | United States | $3.693B | 18.43 |
LivaNova (LIVN) | United Kingdom | $2.706B | 15.49 |
Alphatec Holdings (ATEC) | United States | $2.267B | 0.00 |
Veracyte (VCYT) | United States | $2.202B | 30.42 |
PROCEPT BioRobotics (PRCT) | United States | $2.157B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.052B | 24.49 |
Artivion (AORT) | United States | $2.027B | 102.29 |
Elekta AB (EKTAY) | Sweden | $1.853B | 16.66 |
OPKO Health (OPK) | United States | $1.032B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.001B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $0.993B | 5.69 |
IRadimed (IRMD) | United States | $0.890B | 43.21 |
Tandem Diabetes Care (TNDM) | United States | $0.683B | 0.00 |
SiBone (SIBN) | United States | $0.664B | 0.00 |
AxoGen (AXGN) | United States | $0.645B | 0.00 |
Beta Bionics (BBNX) | United States | $0.622B | 0.00 |
Semler Scientific (SMLR) | United States | $0.522B | 4.20 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.488B | 8.62 |
OrthoPediatrics (KIDS) | United States | $0.472B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.404B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.378B | 0.00 |
Delcath Systems (DCTH) | United States | $0.368B | 87.58 |
AngioDynamics (ANGO) | United States | $0.343B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.333B | 8.46 |
Alpha Tau Medical (DRTS) | Israel | $0.302B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.297B | 0.00 |
NeuroPace (NPCE) | United States | $0.292B | 0.00 |
RxSight (RXST) | United States | $0.272B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.271B | 18.72 |
Neuronetics (STIM) | United States | $0.259B | 0.00 |
908 Devices (MASS) | United States | $0.231B | 0.00 |
Sight Sciences (SGHT) | United States | $0.216B | 0.00 |
CVRx (CVRX) | United States | $0.196B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
Inogen (INGN) | United States | $0.190B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
LENSAR (LNSR) | United States | $0.156B | 0.00 |
Accuray (ARAY) | United States | $0.153B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.128B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.126B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
InspireMD (NSPR) | United States | $0.108B | 0.00 |
Microbot Medical (MBOT) | United States | $0.105B | 0.00 |
Hyperfine (HYPR) | United States | $0.101B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
Spectral AI (MDAI) | United States | $0.060B | 0.00 |
QT Imaging Holdings (QTIH) | United States | $0.055B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
Positron (POSC) | United States | $0.055B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.047B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
Precision Optics (POCI) | United States | $0.037B | 0.00 |
Envoy Medical (COCH) | United States | $0.033B | 0.00 |
DarioHealth (DRIO) | United States | $0.023B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
NexGel (NXGL) | United States | $0.020B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.014B | 0.00 | |
Tenon Medical (TNON) | United States | $0.010B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
PAVmed (PAVM) | United States | $0.008B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.001B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 12.76 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |